bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · Real-Time Price · USD
4.880
+0.800 (19.61%)
At close: Mar 31, 2025, 4:00 PM
4.940
+0.060 (1.23%)
After-hours: Mar 31, 2025, 5:10 PM EDT
bluebird bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 62.31 | 221.76 | 113.01 | 161.16 | 260.63 | Upgrade
|
| Short-Term Investments | - | - | 67.32 | 138.34 | 419.6 | Upgrade
|
| Cash & Short-Term Investments | 62.31 | 221.76 | 180.33 | 299.5 | 680.23 | Upgrade
|
| Cash Growth | -71.90% | 22.97% | -39.79% | -55.97% | -38.52% | Upgrade
|
| Accounts Receivable | 16.68 | 13.01 | 13.13 | 9.11 | 2.37 | Upgrade
|
| Receivables | 16.68 | 13.01 | 13.13 | 9.11 | 2.37 | Upgrade
|
| Inventory | 65.02 | 22.92 | - | - | 10.7 | Upgrade
|
| Prepaid Expenses | 10.63 | 14.8 | 8.62 | 25.63 | 25.72 | Upgrade
|
| Restricted Cash | 0.03 | 9.2 | 1.5 | 2.28 | 1.5 | Upgrade
|
| Other Current Assets | - | - | - | - | 495.02 | Upgrade
|
| Total Current Assets | 154.67 | 281.69 | 203.57 | 336.52 | 1,216 | Upgrade
|
| Property, Plant & Equipment | 237.73 | 267.05 | 298.52 | 101.24 | 84.94 | Upgrade
|
| Long-Term Investments | - | - | 1.41 | 97.11 | 61.45 | Upgrade
|
| Goodwill | 5.65 | 5.65 | 5.65 | 5.65 | 5.65 | Upgrade
|
| Other Intangible Assets | 9.55 | 10.44 | 4.87 | - | 4.4 | Upgrade
|
| Other Long-Term Assets | 52.64 | 54.34 | 55.79 | 53.28 | 409.29 | Upgrade
|
| Total Assets | 460.23 | 619.16 | 569.81 | 593.8 | 1,781 | Upgrade
|
| Accounts Payable | 34.32 | 18.5 | 14.87 | 25.88 | 13.81 | Upgrade
|
| Accrued Expenses | 80.91 | 64.39 | 45.1 | 100.52 | 94.26 | Upgrade
|
| Short-Term Debt | 87.17 | 2.52 | - | - | - | Upgrade
|
| Current Portion of Leases | 114 | 105.91 | 88.25 | 23.15 | 9.71 | Upgrade
|
| Current Unearned Revenue | - | - | - | 2.28 | 1.5 | Upgrade
|
| Other Current Liabilities | 5.06 | 8.8 | 8.37 | 1.15 | 84.3 | Upgrade
|
| Total Current Liabilities | 321.46 | 200.11 | 156.58 | 152.99 | 203.59 | Upgrade
|
| Long-Term Leases | 169.36 | 224.42 | 278.81 | 66.43 | 55.71 | Upgrade
|
| Other Long-Term Liabilities | 0.95 | 0.09 | 0.09 | 0.09 | 166.9 | Upgrade
|
| Total Liabilities | 491.77 | 424.62 | 435.48 | 219.52 | 426.2 | Upgrade
|
| Common Stock | 1.92 | 1.91 | 0.83 | 0.71 | 0.67 | Upgrade
|
| Additional Paid-In Capital | 4,470 | 4,455 | 4,186 | 4,096 | 4,260 | Upgrade
|
| Retained Earnings | -4,501 | -4,260 | -4,048 | -3,720 | -2,901 | Upgrade
|
| Comprehensive Income & Other | -2.13 | -1.8 | -4.07 | -2.91 | -5.51 | Upgrade
|
| Shareholders' Equity | -31.53 | 194.54 | 134.33 | 374.28 | 1,355 | Upgrade
|
| Total Liabilities & Equity | 460.23 | 619.16 | 569.81 | 593.8 | 1,781 | Upgrade
|
| Total Debt | 370.53 | 332.85 | 367.06 | 89.58 | 65.42 | Upgrade
|
| Net Cash (Debt) | -308.22 | -111.09 | -185.32 | 307.03 | 676.26 | Upgrade
|
| Net Cash Growth | - | - | - | -54.60% | -35.41% | Upgrade
|
| Net Cash Per Share | -31.81 | -20.23 | -47.16 | 89.11 | 217.52 | Upgrade
|
| Filing Date Shares Outstanding | 9.79 | 9.7 | 5.32 | 3.57 | 3.36 | Upgrade
|
| Total Common Shares Outstanding | 9.73 | 9.64 | 4.15 | 3.56 | 3.32 | Upgrade
|
| Working Capital | -166.79 | 81.57 | 46.99 | 183.53 | 1,012 | Upgrade
|
| Book Value Per Share | -3.24 | 20.18 | 32.40 | 105.26 | 407.95 | Upgrade
|
| Tangible Book Value | -46.73 | 178.45 | 123.82 | 368.63 | 1,345 | Upgrade
|
| Tangible Book Value Per Share | -4.80 | 18.51 | 29.86 | 103.67 | 404.93 | Upgrade
|
| Machinery | 21.29 | 21.41 | 26.97 | 29.6 | 28.67 | Upgrade
|
| Construction In Progress | 1.41 | 0.56 | - | 0.5 | 0.9 | Upgrade
|
| Leasehold Improvements | 1.36 | 1.25 | - | 0.01 | 5.95 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.